Financial Consulate’s Arcus Biosciences RCUS Stock Holding History

Financial Consulate’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$78	Buy	+3	New	+$85	﹤0.01%	1837

Other funds holding RCUS

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return

Yousif Capital Management Bloomfield Hills, Michigan $8.87B AUM 34.1% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Financial Consulate's RCUS Position: Q3 2026 in Review

Financial Consulate opened a new position in Arcus Biosciences (RCUS) in Q3 2026: 3 shares worth $78. The stake represents ﹤0.01% of the portfolio and ranks #1837 among its holdings.

30 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.

Financial Consulate held 3 shares of Arcus Biosciences worth $78 as of Q3 2026.
Arcus Biosciences was a new Financial Consulate position in Q3 2026.
Arcus Biosciences made up ﹤0.01% of Financial Consulate's portfolio in Q3 2026, its #1837 holding.
30 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.

Based on Financial Consulate's 13F filing for Q3 2026, filed 23 Oct 2026.